Biotech News
Leveragen and Moonlight Bio Partner to Develop Next-Generation T Cell Therapies
Boston-based biotech company Leveragen Inc. has announced a strategic collaboration with Seattle-based Moonlight Bio to develop innovative T cell therapies aimed at treating some of the most challenging cancers. The partnership leverages Leveragen’s Singularity Sapiens Mouse platform, a proprietary tool
31 January 2025